Used primarily as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of sulfonamide-based drugs. It plays a role in the creation of carbonic anhydrase inhibitors, which are investigated for their potential in treating glaucoma, epilepsy, and certain types of cancer. Its structure supports binding to enzyme active sites, enhancing biological activity in target therapeutic agents. Also utilized in medicinal chemistry research for designing novel enzyme inhibitors with improved selectivity and potency.